Our results also suggested that DFX may not only demonstrate the tumor growth inhibitory effect that we reported previously, but may also reduce the migration/invasion of pancreatic cancer cells by abrogating the expression of invasion-related Rho-family G proteins, Rac1 and Cdc42. Here, CDC42 is linked to pancreatic neoplasm.